Skip to main content
Business Blog

What’s the worst that could happen?

Date
It’s a question some business executives ask themselves or their attorneys when considering whether to cross the line into illegal conduct: What are the ramifications of violating consumer protection...
Business Blog

I’ll pay you to give this blog post five stars

Date
Online customer reviews of products and services have become increasingly important in the marketplace. Many consumers rely on them to decide what to buy or where to buy it, and many companies rely on...
Business Blog

Abracadabra: Bad reviews be gone

Date
It’s the oldest trick in the book: Now you see it, now you don’t. This illusion is fine on a Las Vegas stage, but on an online retailer’s website, making negative reviews disappear is hardly magical...
Competition Matters

Physician Group and Healthcare Facility Merger Study

Date
On January 14, 2020, the Federal Trade Commission (FTC) ordered six insurance companies to provide information that will allow the agency to study the effects of consummated physician group and...
Business Blog

A prescription for complying with the Eyeglass Rule

Date
When patients leave the office after an appointment with their eyecare professional, they should have certain things in hand: their coat, their phone – and a copy of their eyeglass prescription. The...
Competition Matters

MMA Reports: No tricks or treats—just facts

Date
With the passage of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), Congress required pharmaceutical companies to file certain patent settlement agreements with the...
Competition Matters

Quo Vadis Post-Actavis?

Date
For more than 15 years, one of the FTC’s top priorities has been to put an end to anticompetitive reverse-payment settlements between brand-name drug makers and their potential generic rivals. In our...
Competition Matters

Power shopping for an alternative buyer

Date
In recent investigations of hospital mergers, the merging parties often make the argument that the acquired firm is flailing, if not outright failing. Thus, the argument goes, the transaction is...